Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomegaly | 5 | 2019 | 41 | 2.330 |
Why?
|
| Mast Cells | 11 | 2019 | 81 | 2.050 |
Why?
|
| TRPV Cation Channels | 7 | 2019 | 24 | 1.680 |
Why?
|
| Calcium Channels | 6 | 2015 | 76 | 1.530 |
Why?
|
| Heart Failure | 4 | 2019 | 235 | 1.070 |
Why?
|
| Acrylamides | 1 | 2019 | 8 | 0.710 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2019 | 20 | 0.710 |
Why?
|
| Calcium Signaling | 5 | 2015 | 101 | 0.710 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 36 | 0.690 |
Why?
|
| Transient Receptor Potential Channels | 3 | 2015 | 8 | 0.690 |
Why?
|
| Insulin | 2 | 2019 | 236 | 0.670 |
Why?
|
| Cannabinoids | 2 | 2018 | 56 | 0.660 |
Why?
|
| Disease Management | 1 | 2018 | 61 | 0.620 |
Why?
|
| Cytokinesis | 1 | 2015 | 11 | 0.510 |
Why?
|
| Ion Channels | 5 | 2007 | 71 | 0.470 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 187 | 0.460 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 27 | 0.460 |
Why?
|
| Animals | 24 | 2020 | 15081 | 0.440 |
Why?
|
| Cell Line | 12 | 2019 | 1354 | 0.440 |
Why?
|
| Pyrazines | 1 | 2012 | 24 | 0.430 |
Why?
|
| Cell Membrane | 4 | 2014 | 381 | 0.430 |
Why?
|
| Receptors, Drug | 4 | 2005 | 58 | 0.420 |
Why?
|
| Pyridines | 1 | 2012 | 116 | 0.410 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 664 | 0.400 |
Why?
|
| Aortic Diseases | 1 | 2011 | 27 | 0.400 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 38 | 0.400 |
Why?
|
| Calcium | 8 | 2015 | 480 | 0.390 |
Why?
|
| Muscle Proteins | 1 | 2011 | 51 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 1609 | 0.380 |
Why?
|
| Receptors, IgE | 2 | 2014 | 23 | 0.380 |
Why?
|
| Membrane Proteins | 5 | 2005 | 517 | 0.360 |
Why?
|
| Myocardium | 1 | 2011 | 235 | 0.340 |
Why?
|
| Chromogranins | 1 | 2008 | 5 | 0.330 |
Why?
|
| Chromogranin A | 1 | 2008 | 7 | 0.330 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 20 | 0.330 |
Why?
|
| Mice | 9 | 2020 | 5913 | 0.320 |
Why?
|
| Rats | 12 | 2019 | 3483 | 0.310 |
Why?
|
| Signal Transduction | 5 | 2019 | 1908 | 0.310 |
Why?
|
| Cell Communication | 1 | 2008 | 97 | 0.310 |
Why?
|
| Inositol Phosphates | 1 | 2005 | 8 | 0.260 |
Why?
|
| Ubiquitin | 1 | 2006 | 78 | 0.260 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2005 | 31 | 0.260 |
Why?
|
| ras Proteins | 1 | 2005 | 51 | 0.250 |
Why?
|
| Molecular Biology | 2 | 2015 | 46 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 194 | 0.240 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 73 | 0.230 |
Why?
|
| Kava | 2 | 2015 | 6 | 0.230 |
Why?
|
| Humans | 20 | 2019 | 37093 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 360 | 0.230 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 22 | 0.220 |
Why?
|
| Schools, Medical | 2 | 2015 | 198 | 0.220 |
Why?
|
| Molecular Structure | 2 | 2019 | 492 | 0.210 |
Why?
|
| Mice, Knockout | 3 | 2020 | 933 | 0.210 |
Why?
|
| Blotting, Western | 4 | 2014 | 859 | 0.190 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 253 | 0.190 |
Why?
|
| Plant Extracts | 2 | 2015 | 286 | 0.180 |
Why?
|
| Cardiolipins | 1 | 2019 | 11 | 0.180 |
Why?
|
| Endocytosis | 1 | 2020 | 113 | 0.170 |
Why?
|
| Glucose | 2 | 2019 | 230 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 623 | 0.170 |
Why?
|
| Oxygen | 1 | 2020 | 207 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2019 | 224 | 0.170 |
Why?
|
| Protein Binding | 4 | 2006 | 972 | 0.160 |
Why?
|
| Male | 6 | 2019 | 20025 | 0.150 |
Why?
|
| Astrocytes | 1 | 2020 | 255 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1518 | 0.140 |
Why?
|
| Microcephaly | 1 | 2016 | 19 | 0.140 |
Why?
|
| Diptera | 1 | 2016 | 11 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 1371 | 0.140 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 13 | 0.140 |
Why?
|
| Fluorescence | 1 | 2016 | 121 | 0.140 |
Why?
|
| Larva | 1 | 2016 | 124 | 0.140 |
Why?
|
| Anthozoa | 1 | 2016 | 24 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 67 | 0.130 |
Why?
|
| Disease Progression | 1 | 2018 | 601 | 0.130 |
Why?
|
| Genome | 1 | 2016 | 125 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 109 | 0.130 |
Why?
|
| Cell Biology | 1 | 2014 | 12 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 262 | 0.120 |
Why?
|
| Mothers | 1 | 2016 | 181 | 0.120 |
Why?
|
| Genomics | 1 | 2016 | 223 | 0.120 |
Why?
|
| Phosphatidylserines | 1 | 2014 | 21 | 0.120 |
Why?
|
| Research | 1 | 2015 | 163 | 0.110 |
Why?
|
| Protein Transport | 3 | 2020 | 302 | 0.110 |
Why?
|
| Nanotubes, Carbon | 1 | 2014 | 79 | 0.110 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 17 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 90 | 0.100 |
Why?
|
| Lactones | 1 | 2012 | 22 | 0.100 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2011 | 12 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 80 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2011 | 37 | 0.100 |
Why?
|
| Universities | 1 | 2015 | 442 | 0.100 |
Why?
|
| Hawaii | 4 | 2016 | 1929 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 123 | 0.090 |
Why?
|
| Phosphorylation | 4 | 2014 | 928 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 85 | 0.090 |
Why?
|
| TRPM Cation Channels | 3 | 2006 | 35 | 0.090 |
Why?
|
| Temperature | 2 | 2016 | 286 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1198 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2014 | 1207 | 0.080 |
Why?
|
| Leukemia, Mast-Cell | 1 | 2008 | 2 | 0.080 |
Why?
|
| Mastocytoma | 1 | 2008 | 4 | 0.080 |
Why?
|
| PC12 Cells | 1 | 2008 | 93 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2011 | 513 | 0.080 |
Why?
|
| Apoptosis | 2 | 2014 | 1398 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2008 | 87 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2005 | 59 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2016 | 661 | 0.080 |
Why?
|
| Membrane Potentials | 2 | 2006 | 223 | 0.070 |
Why?
|
| Biotransformation | 1 | 2007 | 67 | 0.070 |
Why?
|
| Serotonin | 2 | 2004 | 123 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 2231 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 28 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 1742 | 0.070 |
Why?
|
| Prevalence | 2 | 2016 | 1455 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2005 | 10 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2006 | 212 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2006 | 135 | 0.060 |
Why?
|
| Antibodies | 1 | 2005 | 141 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 52 | 0.060 |
Why?
|
| Cations | 1 | 2004 | 45 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2005 | 131 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 295 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 201 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 191 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 83 | 0.060 |
Why?
|
| Interview, Psychological | 1 | 2003 | 61 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 408 | 0.060 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2003 | 32 | 0.060 |
Why?
|
| Capsaicin | 1 | 2003 | 27 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 1568 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 196 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 674 | 0.050 |
Why?
|
| Aggression | 1 | 2003 | 89 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 502 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 626 | 0.050 |
Why?
|
| Inflammation | 1 | 2007 | 618 | 0.050 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2001 | 4 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2001 | 83 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2001 | 100 | 0.050 |
Why?
|
| Logistic Models | 1 | 2003 | 923 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1067 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 404 | 0.040 |
Why?
|
| Nerve Crush | 1 | 1998 | 4 | 0.040 |
Why?
|
| Ligands | 2 | 2015 | 349 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 13 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 1998 | 11 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 11712 | 0.040 |
Why?
|
| Phylogeny | 2 | 2016 | 644 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 515 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2003 | 2026 | 0.040 |
Why?
|
| Blood Banks | 1 | 2016 | 10 | 0.040 |
Why?
|
| Entomology | 1 | 2016 | 1 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2016 | 18 | 0.040 |
Why?
|
| Depression | 1 | 2003 | 712 | 0.040 |
Why?
|
| Microscopy | 1 | 2016 | 32 | 0.040 |
Why?
|
| Calcium Carbonate | 1 | 2016 | 9 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 82 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2016 | 9 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2016 | 24 | 0.030 |
Why?
|
| Photosynthesis | 1 | 2016 | 29 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1180 | 0.030 |
Why?
|
| Anxiety | 1 | 2003 | 754 | 0.030 |
Why?
|
| Symbiosis | 1 | 2016 | 43 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 730 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 237 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2015 | 7 | 0.030 |
Why?
|
| Light | 1 | 2016 | 187 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 448 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 364 | 0.030 |
Why?
|
| Risk Factors | 1 | 2003 | 3562 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 150 | 0.030 |
Why?
|
| Education, Graduate | 1 | 2014 | 27 | 0.030 |
Why?
|
| Hexosaminidase B | 1 | 2014 | 3 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 223 | 0.030 |
Why?
|
| Clathrin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 50 | 0.030 |
Why?
|
| Female | 3 | 2016 | 20969 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2014 | 66 | 0.030 |
Why?
|
| Fullerenes | 1 | 2014 | 31 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 209 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 103 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2014 | 110 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 80 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 461 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 421 | 0.030 |
Why?
|
| TRPC Cation Channels | 2 | 2003 | 7 | 0.030 |
Why?
|
| Hibiscus | 1 | 2012 | 1 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 5363 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 235 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 893 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 1549 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 325 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 681 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 4268 | 0.020 |
Why?
|
| Exocytosis | 1 | 2006 | 47 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2004 | 22 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 50 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 50 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 131 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 143 | 0.010 |
Why?
|
| Cyclohexanols | 1 | 2003 | 7 | 0.010 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 2003 | 4 | 0.010 |
Why?
|
| Carbachol | 1 | 2003 | 19 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2003 | 10 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 2003 | 26 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2003 | 9 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 23 | 0.010 |
Why?
|
| Nociceptors | 1 | 2003 | 32 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 252 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 93 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 61 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 130 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 76 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 158 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 136 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 444 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 523 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 2001 | 7 | 0.010 |
Why?
|
| U937 Cells | 1 | 2001 | 27 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 239 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2001 | 38 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 91 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 269 | 0.010 |
Why?
|
| Sodium | 1 | 2001 | 103 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 269 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 133 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 6741 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 677 | 0.010 |
Why?
|
| Fixatives | 1 | 1998 | 7 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 33 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1998 | 33 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 37 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 453 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 233 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 864 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 10129 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1015 | 0.010 |
Why?
|
| Polymers | 1 | 1998 | 121 | 0.010 |
Why?
|
| Aging | 1 | 1998 | 664 | 0.010 |
Why?
|
| Neurons | 1 | 1998 | 1175 | 0.010 |
Why?
|